Form 4 for GILD Gilead Sciences
Accepted 2025-12-01 00:00:00 ET · period of report 2025-11-28 · accession 0001638643-25-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-12-01 | 2025-11-28 | GILD | O'Day Daniel Patrick | COB, CEO, Dir | S - Sale | $126.54 | -10.0K | 578.0K | -2% | -$1.27M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-28 | S | D | 6,788 | $126.84 | 571,203 | D | — | — | (F3) Sale prices for the transactions reported range from $126.50 to $127.48. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. |
| 2 | Common | Common Stock | 2025-11-28 | S | D | 3,212 | $125.91 | 577,991 | D | — | — | (F2) Sale prices for the transactions reported range from $125.41 to $126.33. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. |